ERCC1 Expression in Metastatic Triple Negative Breast Cancer Patients Treated with Platinum-Based Chemotherapy

BACKGROUND: Possible targeted therapies for metastatic triple negative breast cancer (TNBC) include cytotoxic chemotherapy that causes interstrand breaks (platinum-based drugs). The excision repair cross-complementation 1 (ERCC1) enzyme plays an essential role in the nucleotide excision repair pathw...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Asian Pac J Cancer Prev
Prif Awduron: Baiomy, Mohamed Ali EL, El Kashef, Wagdi F
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: West Asia Organization for Cancer Prevention 2017
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5454751/
https://ncbi.nlm.nih.gov/pubmed/28345838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2017.18.2.507
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg